Northwest Biotherapeutics INC (NWBO) — DEF 14A Filings
All DEF 14A filings from Northwest Biotherapeutics INC. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
NWBO Seeks 53% Stock Authorization Hike, Board Election at Annual Meeting
— Nov 28, 2025 Risk: high
Northwest Biotherapeutics, Inc. (NWBO) is holding its Annual Meeting of Stockholders on December 29, 2025, to address several key proposals. The company seeks t -
Northwest Biotherapeutics Sets 2024 Annual Meeting for June 29
— Jun 3, 2024 Risk: medium
Northwest Biotherapeutics, Inc. has scheduled its 2024 Annual Meeting of Stockholders for June 29, 2024, at 1:30 p.m. local time. The meeting will take place at
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX